NEU 0.16% $19.06 neuren pharmaceuticals limited

An aquirer will likely have many other parts. So the exposure...

  1. 5,717 Posts.
    lightbulb Created with Sketch. 272


    An aquirer will likely have many other parts. So the exposure for Neurens assets would be highly diluted if a current shareholder invested in the aquirer.

    Thus it would`t be effective. IMO

    Best to get the maximum possible when/if TO occurs. Not good enough offer, send `em packing.

    It will really depend if there is more than 1 suitor.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.06
Change
-0.030(0.16%)
Mkt cap ! $2.433B
Open High Low Value Volume
$19.08 $19.42 $18.54 $4.293M 224.4K

Buyers (Bids)

No. Vol. Price($)
3 4002 $19.04
 

Sellers (Offers)

Price($) Vol. No.
$19.11 448 1
View Market Depth
Last trade - 16.10pm 13/05/2024 (20 minute delay) ?
Last
$19.10
  Change
-0.030 ( 0.36 %)
Open High Low Volume
$19.13 $19.41 $18.95 87429
Last updated 15.59pm 13/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.